Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe.

Garsa A, Ho JC, Hu C, Chang EL.

Chin Clin Oncol. 2019 Oct;8(S1):S20. doi: 10.21037/cco.2019.02.06. Epub 2019 Apr 17. No abstract available.

2.

Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria.

Kumariya R, Garsa AK, Rajput YS, Sood SK, Akhtar N, Patel S.

Microb Pathog. 2019 Mar;128:171-177. doi: 10.1016/j.micpath.2019.01.002. Epub 2019 Jan 3. Review.

PMID:
30610901
3.

Bovicins: The Bacteriocins of Streptococci and Their Potential in Methane Mitigation.

Garsa AK, Choudhury PK, Puniya AK, Dhewa T, Malik RK, Tomar SK.

Probiotics Antimicrob Proteins. 2019 Dec;11(4):1403-1413. doi: 10.1007/s12602-018-9502-z.

PMID:
30603877
4.

Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.

Floberg JM, DeWees TA, Chin RI, Garsa AA, Dehdashti F, Nussenbaum B, Oppelt PJ, Adkins DR, Gay HA, Thorstad WL.

Head Neck. 2018 Oct;40(10):2280-2287. doi: 10.1002/hed.25337. Epub 2018 Jul 26.

PMID:
30051553
5.

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS).

Abraham C, Garsa A, Badiyan SN, Drzymala R, Yang D, DeWees T, Tsien C, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson C.

Adv Radiat Oncol. 2017 Nov 24;3(2):146-153. doi: 10.1016/j.adro.2017.11.003. eCollection 2018 Apr-Jun.

6.

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy.

Chapman CH, McGuinness C, Gottschalk AR, Yom SS, Garsa AA, Anwar M, Braunstein SE, Sudhyadhom A, Keall P, Descovich M.

J Appl Clin Med Phys. 2018 Jul;19(4):48-57. doi: 10.1002/acm2.12338. Epub 2018 Apr 26.

7.

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.

Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS.

Head Neck. 2018 Jul;40(7):1406-1414. doi: 10.1002/hed.25114. Epub 2018 Mar 10.

PMID:
29524273
8.

Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.

Yu Y, El-Sayed IH, McDermott MW, Theodosopoulos PV, van Zante A, Kased N, Glastonbury CM, Garsa AA, Yom SS.

Laryngoscope. 2018 Oct;128(10):2226-2233. doi: 10.1002/lary.27126. Epub 2018 Feb 10.

PMID:
29427378
9.

Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.

Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, El-Sayed IH, Eisele DW, Yom SS.

Head Neck. 2018 May;40(5):904-916. doi: 10.1002/hed.25028. Epub 2017 Dec 6.

PMID:
29210145
10.

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy.

Vasudevan HN, Raleigh DR, Johnson J, Garsa AA, Theodosopoulos PV, Aghi MK, Ames C, McDermott MW, Barani IJ, Braunstein SE.

Front Surg. 2017 Jun 23;4:35. doi: 10.3389/fsurg.2017.00035. eCollection 2017.

11.

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.

Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA.

Cancer. 2017 Jun 1;123(11):2054-2060. doi: 10.1002/cncr.30601. Epub 2017 Feb 7.

12.

Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy.

Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS.

J Med Imaging Radiat Oncol. 2016 Aug;60(4):560-7. doi: 10.1111/1754-9485.12452. Epub 2016 Mar 28.

PMID:
27020481
13.

Contribution of Cell Surface Hydrophobicity in the Resistance of Staphylococcus aureus against Antimicrobial Agents.

Lather P, Mohanty AK, Jha P, Garsa AK.

Biochem Res Int. 2016;2016:1091290. doi: 10.1155/2016/1091290. Epub 2016 Feb 7.

14.

Increased membrane surface positive charge and altered membrane fluidity leads to cationic antimicrobial peptide resistance in Enterococcus faecalis.

Kumariya R, Sood SK, Rajput YS, Saini N, Garsa AK.

Biochim Biophys Acta. 2015 Jun;1848(6):1367-75. doi: 10.1016/j.bbamem.2015.03.007. Epub 2015 Mar 14.

15.

Transperineal ultrasound-guided implantation of electromagnetic transponders in the prostatic fossa for localization and tracking during external beam radiation therapy.

Garsa AA, Verma V, Michalski JM, Gay HA.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):415-21. doi: 10.1016/j.prro.2014.01.004. Epub 2014 Feb 28.

PMID:
25407864
16.

Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.

Garsa AA, Badiyan SN, DeWees T, Simpson JR, Huang J, Drzymala RE, Barani IJ, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson CG.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):407-13. doi: 10.1016/j.ijrobp.2014.05.047. Epub 2014 Jul 30.

PMID:
25084610
17.

Bacteriocin production and different strategies for their recovery and purification.

Garsa AK, Kumariya R, Sood SK, Kumar A, Kapila S.

Probiotics Antimicrob Proteins. 2014 Mar;6(1):47-58. doi: 10.1007/s12602-013-9153-z. Review.

PMID:
24676767
18.

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.

Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL.

J Radiat Oncol. 2013 Mar;2(1):27-34.

19.

Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.

Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):801-5. doi: 10.1016/j.ijrobp.2013.12.014. Epub 2014 Jan 22.

PMID:
24462385
20.

A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.

Garsa AA, Ferraro DJ, DeWees TA, Deshields TL, Margenthaler JA, Cyr AE, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Ochoa LL, Zoberi I.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1043-50. doi: 10.1016/j.ijrobp.2013.09.009. Epub 2013 Oct 22.

21.

Highly Specific Culture-Independent Detection of YGNGV Motif-Containing Pediocin-Producing Strains.

Sood SK, Vijay Simha B, Kumariya R, Garsa AK, Mehla J, Meena S, Lather P.

Probiotics Antimicrob Proteins. 2013 Mar;5(1):37-42. doi: 10.1007/s12602-012-9114-y.

PMID:
26782603
22.

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis.

Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa AA, Dewees T, Bradley JD, Robinson CG.

Radiat Oncol. 2013 Jan 3;8:4. doi: 10.1186/1748-717X-8-4.

23.

Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study.

Garsa AA, Ferraro DJ, DeWees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):965-70. doi: 10.1016/j.ijrobp.2012.08.027. Epub 2012 Oct 9.

24.

Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer.

Garsa AA, Ferraro DJ, Dewees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I.

Brachytherapy. 2013 Mar-Apr;12(2):99-106. doi: 10.1016/j.brachy.2012.04.005. Epub 2012 Jun 20.

25.

Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation.

Ferraro DJ, Garsa AA, DeWees TA, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I.

Radiat Oncol. 2012 Mar 29;7:53. doi: 10.1186/1748-717X-7-53.

26.

Simple and rapid purification of pediocin PA-1 from Pediococcus pentosaceous NCDC 273 suitable for industrial application.

Vijay Simha B, Sood SK, Kumariya R, Garsa AK.

Microbiol Res. 2012 Oct 12;167(9):544-9. doi: 10.1016/j.micres.2012.01.001. Epub 2012 Jan 23.

27.

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA.

Pharmacogenomics. 2008 Oct;9(10):1403-17. doi: 10.2217/14622416.9.10.1403.

28.

Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study.

Garsa AA, Andrade RS, Heron DE, Beriwal S, Kim H, Brandner E, Kuo G, Chen H, Gerszten K, Yue JN, Huq MS, Lee J, Lalonde R, Wu A.

Int J Gynecol Cancer. 2007 Jan-Feb;17(1):55-60.

PMID:
17291232
29.

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.

Henningsson A, Marsh S, Loos WJ, Karlsson MO, Garsa A, Mross K, Mielke S, ViganĂ² L, Locatelli A, Verweij J, Sparreboom A, McLeod HL.

Clin Cancer Res. 2005 Nov 15;11(22):8097-104.

30.

Pyrosequencing of clinically relevant polymorphisms.

Marsh S, King CR, Garsa AA, McLeod HL.

Methods Mol Biol. 2005;311:97-114.

PMID:
16100402
31.

CYP3A4 and CYP3A5 genotyping by Pyrosequencing.

Garsa AA, McLeod HL, Marsh S.

BMC Med Genet. 2005 May 9;6:19.

Supplemental Content

Support Center